Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats.

Ramalingayya GV, Cheruku SP, Nayak PG, Kishore A, Shenoy R, Rao CM, Krishnadas N.

Drug Des Devel Ther. 2017 Mar 29;11:1011-1026. doi: 10.2147/DDDT.S103511. eCollection 2017.

2.

Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats.

Lomeli N, Di K, Czerniawski J, Guzowski JF, Bota DA.

Free Radic Biol Med. 2017 Jan;102:274-286. doi: 10.1016/j.freeradbiomed.2016.11.046. Epub 2016 Nov 28.

3.

Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer.

Himmel LE, Lustberg MB, DeVries AC, Poi M, Chen CS, Kulp SK.

Exp Toxicol Pathol. 2016 Oct;68(9):505-515. doi: 10.1016/j.etp.2016.08.001. Epub 2016 Aug 21.

4.

Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin Lymphoma - a commentary on report from Krull and colleagues.

Esiashvili N, Khan M, Flowers C.

Transl Pediatr. 2013 Jan;2(1):1-2. doi: 10.3978/j.issn.2224-4336.2012.12.02. No abstract available.

5.

PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth.

Jiang ZG, Fuller SA, Ghanbari HA.

Oxid Med Cell Longev. 2016;2016:9392404. doi: 10.1155/2016/9392404. Epub 2015 Nov 10.

6.

Chemotherapy-related changes in cognitive functioning.

Schagen SB, Wefel JS.

EJC Suppl. 2013 Sep;11(2):225-32. doi: 10.1016/j.ejcsup.2013.07.007. Review. No abstract available.

7.

Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.

Klein R, Myers CE, Lee KE, Paterson AD, Cruickshanks KJ, Tsai MY, Gangnon RE, Klein BE.

JAMA Ophthalmol. 2015 Sep;133(9):1054-61. doi: 10.1001/jamaophthalmol.2015.2239.

8.

Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways.

Salas-Ramirez KY, Bagnall C, Frias L, Abdali SA, Ahles TA, Hubbard K.

Behav Brain Res. 2015 Oct 1;292:133-41. doi: 10.1016/j.bbr.2015.06.028. Epub 2015 Jun 19.

9.

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Wefel JS, Kesler SR, Noll KR, Schagen SB.

CA Cancer J Clin. 2015 Mar;65(2):123-38. doi: 10.3322/caac.21258. Epub 2014 Dec 5. Review.

10.

Prevalence, mechanisms, and management of cancer-related cognitive impairment.

Janelsins MC, Kesler SR, Ahles TA, Morrow GR.

Int Rev Psychiatry. 2014 Feb;26(1):102-13. doi: 10.3109/09540261.2013.864260. Review.

11.

Ribosomal S6 Kinase 2 (RSK2) maintains genomic stability by activating the Atm/p53-dependent DNA damage pathway.

Lim HC, Xie L, Zhang W, Li R, Chen ZC, Wu GZ, Cui SS, Tan EK, Zeng L.

PLoS One. 2013 Sep 23;8(9):e74334. doi: 10.1371/journal.pone.0074334. eCollection 2013.

12.

Translational approaches to treatment-induced symptoms in cancer patients.

Dantzer R, Meagher MW, Cleeland CS.

Nat Rev Clin Oncol. 2012 May 29;9(7):414-26. doi: 10.1038/nrclinonc.2012.88. Review.

13.

Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats.

Long JM, Lee GD, Kelley-Bell B, Spangler EL, Perez EJ, Longo DL, de Cabo R, Zou S, Rapp PR.

Pharmacol Biochem Behav. 2011 Nov;100(1):205-11. doi: 10.1016/j.pbb.2011.08.012. Epub 2011 Aug 22.

14.

The effects of cyclophosphamide on hippocampal cell proliferation and spatial working memory in rat.

Lyons L, Elbeltagy M, Bennett G, Wigmore P.

PLoS One. 2011;6(6):e21445. doi: 10.1371/journal.pone.0021445. Epub 2011 Jun 22.

15.
16.

An update on cancer- and chemotherapy-related cognitive dysfunction: current status.

Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR.

Semin Oncol. 2011 Jun;38(3):431-8. doi: 10.1053/j.seminoncol.2011.03.014. Review.

17.

A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog').

Raffa RB.

J Clin Pharm Ther. 2011 Jun;36(3):257-9. doi: 10.1111/j.1365-2710.2010.01188.x. Epub 2010 Aug 24.

18.

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.

Lyons L, ElBeltagy M, Umka J, Markwick R, Startin C, Bennett G, Wigmore P.

Psychopharmacology (Berl). 2011 May;215(1):105-15. doi: 10.1007/s00213-010-2122-2. Epub 2010 Dec 22.

19.
20.

Mammary tumors induce select cognitive impairments.

Pyter LM, Cochrane SF, Ouwenga RL, Patel PN, Pineros V, Prendergast BJ.

Brain Behav Immun. 2010 Aug;24(6):903-7. doi: 10.1016/j.bbi.2010.02.004. Epub 2010 Feb 25.

Supplemental Content

Support Center